IL160455A0 - Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity - Google Patents

Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity

Info

Publication number
IL160455A0
IL160455A0 IL16045502A IL16045502A IL160455A0 IL 160455 A0 IL160455 A0 IL 160455A0 IL 16045502 A IL16045502 A IL 16045502A IL 16045502 A IL16045502 A IL 16045502A IL 160455 A0 IL160455 A0 IL 160455A0
Authority
IL
Israel
Prior art keywords
hydroxy
phenyl
substituted
methyl
dehydrogenase activity
Prior art date
Application number
IL16045502A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL160455A0 publication Critical patent/IL160455A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16045502A 2001-08-23 2002-08-21 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity IL160455A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120471.8A GB0120471D0 (en) 2001-08-23 2001-08-23 Chemical compounds
PCT/GB2002/003867 WO2003017995A1 (en) 2001-08-23 2002-08-21 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity

Publications (1)

Publication Number Publication Date
IL160455A0 true IL160455A0 (en) 2004-07-25

Family

ID=9920849

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16045502A IL160455A0 (en) 2001-08-23 2002-08-21 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity

Country Status (23)

Country Link
US (2) US20050026931A1 (uk)
EP (1) EP1425003A1 (uk)
JP (1) JP2005506976A (uk)
KR (1) KR20040030164A (uk)
CN (2) CN101328157A (uk)
AR (1) AR037497A1 (uk)
AU (1) AU2002321520B2 (uk)
BR (1) BR0212043A (uk)
CA (1) CA2458121A1 (uk)
CO (1) CO5560539A2 (uk)
GB (1) GB0120471D0 (uk)
HU (1) HUP0401149A2 (uk)
IL (1) IL160455A0 (uk)
IS (1) IS7157A (uk)
MX (1) MXPA04001552A (uk)
NO (1) NO326745B1 (uk)
NZ (1) NZ531261A (uk)
PL (1) PL368615A1 (uk)
RU (1) RU2301805C2 (uk)
SA (1) SA02230268B1 (uk)
UA (1) UA77967C2 (uk)
WO (1) WO2003017995A1 (uk)
ZA (1) ZA200401375B (uk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101108196B1 (ko) * 2009-11-04 2012-01-31 (주)유로파 쓰레기 자동 집하시설의 관로 전환기
RU2693457C2 (ru) * 2013-07-18 2019-07-03 Фондацьоне Иституто Итальяно Ди Текнолоджия Фенилкарбаматы и их применения в качестве ингибиторов фермента гидролазы амидов жирных кислот (faah) и модуляторов d3 допаминового рецептора (d3dr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537618A (en) * 1982-05-26 1985-08-27 Ciba Geigy Corporation N-phenylsulfonyl-N'-pyrimidinylureas
EP0539329A1 (de) * 1991-10-25 1993-04-28 Ciba-Geigy Ag Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
GB9310095D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
GB9804648D0 (en) * 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) * 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) * 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
DK1214296T3 (da) * 1999-09-04 2004-07-05 Astrazeneca Ab Substituerede N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluorpropanamidderivater, der forhöjer pyruvatdehydrogenaseaktivitet

Also Published As

Publication number Publication date
KR20040030164A (ko) 2004-04-08
CN101328157A (zh) 2008-12-24
ZA200401375B (en) 2004-11-17
GB0120471D0 (en) 2001-10-17
UA77967C2 (en) 2007-02-15
RU2004108466A (ru) 2005-09-20
RU2301805C2 (ru) 2007-06-27
AR037497A1 (es) 2004-11-17
US20050026931A1 (en) 2005-02-03
CO5560539A2 (es) 2005-09-30
WO2003017995A1 (en) 2003-03-06
BR0212043A (pt) 2004-08-17
JP2005506976A (ja) 2005-03-10
NZ531261A (en) 2005-09-30
EP1425003A1 (en) 2004-06-09
NO20040725L (no) 2004-02-19
IS7157A (is) 2004-02-19
HUP0401149A2 (hu) 2004-12-28
US20070208032A1 (en) 2007-09-06
CN1571665A (zh) 2005-01-26
SA02230268B1 (ar) 2007-02-17
AU2002321520B2 (en) 2008-06-12
NO326745B1 (no) 2009-02-09
MXPA04001552A (es) 2004-05-17
CA2458121A1 (en) 2003-03-06
PL368615A1 (en) 2005-04-04

Similar Documents

Publication Publication Date Title
HK1061852A1 (en) 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
IL160081A0 (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
SI1583763T1 (sl) Benzoazolilpiperazinski derivati, ki imajo VR1 antagonistično delovanje
IL161990A0 (en) Cetylene derivatives having mglur 5antagonistic activity
HK1068338A1 (en) Piperazine derivatives having sst1 antagonistic activity.
MXPA03008338A (es) Derivados de piperazina.
MXPA03008140A (es) Amidas de acido benzofuran-2-carboxilico sustituidas.
HK1045496A1 (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
HK1070646A1 (en) Neurotensin active 2,3-diaryl-pyrazolidine derivatives
MXPA03008394A (es) Derivados de biuretano.
IL160455A0 (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
SI1214296T1 (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
HK1064940A1 (en) Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
AU2003255737A8 (en) Antimicrobial 2, 4-diamino-pteridine derivatives
TJ432B (en) S(7-methyl-5-oxo-5h-1,3,4-thiadi-zoloÄ3,2-aÜpyrimidine-2-yl)-isotiuron gydrobromide le possesesed ofantibakterial activity
AU2002309003A1 (en) 4-hydroxpiperidine derivative with analgetic activity
AU2002244013A1 (en) Mutant pro-neurotrophin with improved activity
AU2002327845A1 (en) Iodobenzopyran-4-one derivatives having fungicidal activity
GB0216664D0 (en) 1,4-Dihydro-1,4-diphenylpyridine derivatives
GB0112516D0 (en) V.i.s.c
AU2002236054A1 (en) Indolone derivatives having vascular-damaging activity
GB0130189D0 (en) Spot on
ZA200203157B (en) Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors.